4SC AG RPE
¿Qué es el RPE de 4SC AG?
El RPE de 4SC AG es €53.619k
¿Cuál es la definición de RPE?
Ingresos por empleado (RPE) son ingresos divididos por el número de empleados de una organización.
RPE de compañías en Sector Health Care en XETRA en comparadas con 4SC AG
¿Qué hace 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Empresas con rpe similar a 4SC AG
- Jumia Technologies AG tiene RPE de $53.468k
- LSL Property Services Plc tiene RPE de £53.511k
- Neovasc tiene RPE de $53.549k
- Stanley Furniture tiene RPE de $53.560k
- VR Education Plc tiene RPE de €53.618k
- City of London plc tiene RPE de £53.618k
- 4SC AG tiene RPE de €53.619k
- Greenpro Capital tiene RPE de $53.672k
- Xinyang Maojian tiene RPE de HKD$53.752k
- I.Céram SA tiene RPE de €53.842k
- Génomic Vision SA tiene RPE de €53.852k
- Profound Medical tiene RPE de $53.973k
- Nikola tiene RPE de $54.018k